Flora Growth (NASDAQ:FLGC) Corp (NASDAQ: FLGC) is a vertically integrated cannabis and hemp company engaged in the cultivation, extraction, formulation and distribution of cannabinoid-based products. Its portfolio encompasses a broad range of offerings, including oils, vape cartridges, edibles, topicals and patent-pending delivery systems designed for both medical and wellness applications.
Founded in 2018, Flora Growth has established cultivation and processing operations in Uruguay’s greenhouse hubs, complemented by extraction and formulation laboratories in Florida. This geographic footprint enables the company to supply regulated markets across the Americas and to explore select opportunities in Europe and Latin America through both branded and private-label channels.
The company places a strong emphasis on research and development, with a multidisciplinary team dedicated to advancing nanoemulsion technologies, transdermal patches and other novel delivery methods. These R&D efforts aim to improve product efficacy in areas such as pain management, dermatology and general wellness, while complying with evolving regulatory standards.
Headquartered in Vancouver, British Columbia, with regional offices in Montevideo and Miami, Flora Growth is led by Chairman and CEO Richard Pattison. Under his guidance, the management team leverages deep expertise in agronomy, bioprocessing and international business development to navigate complex market dynamics and drive long-term growth.
